Cargando…

Cardiogenic shock in the Aachen Digital Myocardial Infarction Registry

Detalles Bibliográficos
Autores principales:	Kersten, A, Merx, M, Dückers, H, Kelm, M, Lepper, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095290/ http://dx.doi.org/10.1186/cc5397

Ejemplares similares

Infections after myocardial infarction and cardiogenic shock and their reflection by inflammation parameters
por: Mitterhammer, H, et al.
Publicado: (2005)

BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
por: Lemm, H, et al.
Publicado: (2010)

Intra-aortic balloon counterpulsation: impact on patient hemodynamics in acute myocardial infarction complicated by cardiogenic shock
por: Brazdzionyte, J, et al.
Publicado: (2007)

Effects of establishing an intermediate care unit: changes in case mix at a cardiologic-pulmonary ICU
por: Kersten, AM, et al.
Publicado: (2009)

Pharmacological CCR1 blockade limits infarct size and preserves cardiac function in a chronic model of myocardial ischemia/reperfusion
por: Van de Sandt, A, et al.
Publicado: (2011)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

Long-term outcome after angioplasty in cardiogenic shock
por: Bulpa, P, et al.
Publicado: (2004)

Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock: CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry
por: Gąsior, Mariusz, et al.
Publicado: (2021)

Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock
por: Acharya, Deepak
Publicado: (2018)

Copeptin is a strong and independent predictor of outcome in cardiogenic shock
por: Meyer, B, et al.
Publicado: (2009)

A Review of Cardiogenic Shock in Acute Myocardial Infarction
por: Khalid, L, et al.
Publicado: (2008)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Induction of mild hypothermia in cardiac arrest survivors with cardiogenic shock syndrome
por: Skulec, R, et al.
Publicado: (2007)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Paraganglioma masquerading as acute myocardial infarction and cardiogenic shock
por: Ahmad, Tanveer, et al.
Publicado: (2016)

Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock
por: Jung, Richard G., et al.
Publicado: (2021)

Blood lactate normalization following venoarterial ECMO institution for refractory cardiogenic shock
por: Bottiroli, M, et al.
Publicado: (2015)

In-hospital and long-term mortality after venoarterial ECMO for refractory cardiogenic shock
por: Bottiroli, M, et al.
Publicado: (2015)

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
por: O’Neill, William W, et al.
Publicado: (2014)

Value of APACHE II score to predict mortality in cardiogenic shock patients of a cardiologic ICU
por: Ribeiro, M, et al.
Publicado: (2006)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Extracorporeal membrane oxygenation (ECMO) in the management of non-surgical patients with cardiogenic shock and cardiac arrest
por: Ostadal, P, et al.
Publicado: (2015)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
por: De Luca, Leonardo, et al.
Publicado: (2023)

Invasive Phenoprofiling of Acute-Myocardial-Infarction-Related Cardiogenic Shock
por: Ortega-Hernández, Jorge A., et al.
Publicado: (2023)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Pulmonary artery catheter use in acute myocardial infarction‐cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2020)

Infarct zone viability in stable patients with ST-elevation myocardial infarction not undergoing reperfusion - the COAT trial registry
por: Malek, Lukasz A, et al.
Publicado: (2011)

Multimodal MRI in the course of cardiac wound healing after myocardial infarction
por: Bönner, Florian, et al.
Publicado: (2012)

Management of cardiogenic shock complicating acute myocardial infarction: A review
por: Shah, Ashish H., et al.
Publicado: (2019)

Prognosis value of dynamic variation of tissue oxygen saturation during severe cardiogenic shock
por: Gaudard, P, et al.
Publicado: (2011)

Airway pressure release ventilation restores hemodynamic stability in patients with cardiogenic shock: initial experience in cardiac intensive care
por: Taha, A, et al.
Publicado: (2014)

Mixed and central venous oxygen saturation are not interchangeable in patients with cardiogenic shock after cardiac surgery
por: Romagnoli, S, et al.
Publicado: (2013)

Extracorporeal life support for refractory cardiogenic shock. etiology and outcome in a tertiary referral hospital
por: Hurtado-Doce, AI, et al.
Publicado: (2015)

A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock
por: Kim, Hong Nyun, et al.
Publicado: (2020)

Factors Associated with the Prognosis of Patients with Acute Myocardial Infarction and Cardiogenic Shock
por: Feng, Ke-Fu, et al.
Publicado: (2021)

Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction
por: Muzafarova, Tamilla, et al.
Publicado: (2022)

Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
por: Somaschini, Alberto, et al.
Publicado: (2023)

Aachen cathedral

Cannot write session to /tmp/vufind_sessions/sess_6j6176f0320tsq1vqgm68oafef